What “research use only” means

“Research use only” is widely treated as a disclaimer — a form of words that changes what a seller is responsible for. It is not. It is a description of what a product is, and the description is either accurate or it is not.

What the phrase actually does

Material supplied for research is not manufactured, tested, documented or released to the standards that apply to medicines. There is no marketing authorisation behind it, no regulator has assessed it, and it has not been through the manufacturing quality system that a licensed product requires. Saying so is a statement of fact about the supply chain.

What the phrase does not do is alter the product’s legal character. Under the Human Medicines Regulations 2012, something can be a medicinal product by virtue of how it is presented — the claims made about it, the context it is sold in, the instructions supplied with it. A label saying “research use only” attached to copy describing physiological effects and quantities to administer does not resolve that tension. It documents it.

What follows for this site

If the description has to be accurate, it constrains what we publish. So:

• No guidance on human use. Not quantities, not schedules, not routes of administration, not comparisons between compounds framed around what someone might experience. Publishing that would make the material medicinal by presentation regardless of any label.
• No effect claims. Product pages describe the material: sequence, form, purity, batch. What a compound does in an organism is a question for the literature, not for a page whose purpose is to sell it.
• No therapeutic framing. Including the softened kind — “supports”, “promotes”, “optimises” — which is the same claim with the verb changed.
• Documentation instead. The useful thing a supplier can actually offer is evidence about the material: what it is, how pure, which batch, tested by whom. That is what the certificates page is for.

This is why our knowledge articles are about technique, storage and documentation. It is not evasion. It is the only category of advice a supplier is genuinely well placed to give.

What follows for the purchaser

Ordering research material is a statement that you have a research purpose for it, and that you are equipped to handle it. Practically, that means somewhere appropriate to store and use it, an assessment of the hazards under COSHH or its equivalent, and a route for disposal.

It also means accepting the limits of what you are buying. Research-grade material carries no assurance of sterility, no endotoxin limit, no stability data and no pharmacopoeial release. Those absences are not oversights to be worked around; they are what distinguishes this category from a medicine.

Questions we will not answer

We are asked, fairly often, what quantity someone should use, how compounds compare in practice, or what to expect. We do not answer those questions — not by email, not by phone, and not with a hedge attached.

Answering would be practising medicine without the qualifications, the authorisation or the patient. It would also make every “research use only” statement on this site untrue, which would be worse for anyone relying on the rest of what we publish.

Questions about purity, batch documentation, storage, handling and shipping are a different matter, and we would rather have more of those.

A note on prescription-only substances

Some compounds studied in research settings are also licensed medicines in Great Britain, or close analogues of them. For those, supply to the public without a prescription is an offence under the Human Medicines Regulations, and a research-use label does not create an exemption.

If you are uncertain whether something falls into that category, the MHRA is the authority, not us.